ID   SMS1_HUMAN              Reviewed;         419 AA.
AC   Q86VZ5; Q68U43; Q6EKK0; Q75SP1;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-FEB-2004, sequence version 2.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=Phosphatidylcholine:ceramide cholinephosphotransferase 1;
DE            EC=2.7.8.27;
DE   AltName: Full=Medulla oblongata-derived protein;
DE            Short=Protein Mob;
DE   AltName: Full=Sphingomyelin synthase 1;
DE   AltName: Full=Transmembrane protein 23;
GN   Name=SGMS1; Synonyms=MOB, SMS1, TMEM23;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH42899.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=14976195; DOI=10.1074/jbc.M401205200;
RA   Yamaoka S., Miyaji M., Kitano T., Umehara H., Okazaki T.;
RT   "Expression cloning of a human cDNA restoring sphingomyelin synthesis
RT   and cell growth in sphingomyelin synthase-defective lymphoid cells.";
RL   J. Biol. Chem. 279:18688-18693(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAP37279.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Yuan H.F., Wang X., Wang D.M., Li H.M., Feng K., Bai C.X., Zhang R.,
RA   Chen L., Li Y.H., Gao Y.H., Zhen M., Yue W., Xie C., Xie X.Y.,
RA   Niu L.L., Gao W.J., Zhang J., Cao H., Pei X.T.;
RT   "Complete cDNA sequence of a novel gene, human mob.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAP37279.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Zhao H., Miao S.Y., Zhang X.D., Liang G., Qiao Y., Wang L.F.;
RT   "A new spermatogenesis-related gene.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph {ECO:0000312|EMBL:AAH42899.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-296 (ISOFORM 2), IDENTIFICATION
RP   (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum;
RX   PubMed=15315829; DOI=10.1016/j.gene.2004.06.003;
RA   Vladychenskaya I.P., Dergunova L.V., Dmitrieva V.G., Limborska S.A.;
RT   "Human gene MOB: structure specification and aspects of
RT   transcriptional activity.";
RL   Gene 338:257-265(2004).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAP37279.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-283 (ISOFORM 1).
RA   Vladychenskaya I.P., Dergunova L.V., Limborska S.A., Dmitrieva V.G.;
RT   "Structure and functional organization of a novel human brain-specific
RT   gene MOB encoding a phylogenetically conserved transmembrane
RT   protein.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   IDENTIFICATION (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11841947; DOI=10.1016/S1389-0344(01)00110-1;
RA   Vladychenskaya I.P., Dergunova L.V., Limborska S.A.;
RT   "In vitro and in silico analysis of the predicted human MOB gene
RT   encoding a phylogenetically conserved transmembrane protein.";
RL   Biomol. Eng. 18:263-268(2002).
RN   [10] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ENZYME REGULATION,
RP   AND TOPOLOGY OF C-TERMINUS.
RX   PubMed=14685263; DOI=10.1038/sj.emboj.7600034;
RA   Huitema K., Van Den Dikkenberg J., Brouwers J.F.H.M., Holthuis J.C.;
RT   "Identification of a family of animal sphingomyelin synthases.";
RL   EMBO J. 23:33-44(2004).
RN   [11]
RP   OVEREXPRESSION IN MOUSE.
RX   PubMed=16508036; DOI=10.1194/jlr.M600040-JLR200;
RA   Dong J., Liu J., Lou B., Li Z., Ye X., Wu M., Jiang X.-C.;
RT   "Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2
RT   increases the atherogenic potential in mice.";
RL   J. Lipid Res. 47:1307-1314(2006).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17449912; DOI=10.1074/jbc.M702423200;
RA   Tafesse F.G., Huitema K., Hermansson M., van der Poel S.,
RA   van den Dikkenberg J., Uphoff A., Somerharju P., Holthuis J.C.M.;
RT   "Both sphingomyelin synthases SMS1 and SMS2 are required for
RT   sphingomyelin homeostasis and growth in human HeLa cells.";
RL   J. Biol. Chem. 282:17537-17547(2007).
RN   [13]
RP   ACTIVE SITES, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-289;
RP   HIS-291; HIS-334 AND ASP-338.
RX   PubMed=18694848; DOI=10.1016/j.bbalip.2008.07.002;
RA   Yeang C., Varshney S., Wang R., Zhang Y., Ye D., Jiang X.C.;
RT   "The domain responsible for sphingomyelin synthase (SMS) activity.";
RL   Biochim. Biophys. Acta 1781:610-617(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Sphingomyelin synthases synthesize the sphingolipid,
CC       sphingomyelin, through transfer of the phosphatidyl head group,
CC       phosphatidylcholine, on to the primary hydroxyl of ceramide. The
CC       reaction is bidirectional depending on the respective levels of
CC       the sphingolipid and ceramide. Golgi apparatus SMS1 directly and
CC       specifically recognizes the choline head group on the substrate,
CC       requiring two fatty chains on the choline-P donor molecule in
CC       order to be recognized efficiently as a substrate. Major form in
CC       macrophages. Required for cell growth in certain cell types such
CC       as HeLa cells. Suppresses BAX-mediated apoptosis and also prevents
CC       cell death in response to stimuli such as hydrogen peroxide,
CC       osmotic stress, elevated temperature and exogenously supplied
CC       sphingolipids. May protect against cell death by reversing the
CC       stress-inducible increase in levels of proapoptotic ceramide.
CC       {ECO:0000269|PubMed:14685263, ECO:0000269|PubMed:17449912}.
CC   -!- CATALYTIC ACTIVITY: A ceramide + a phosphatidylcholine = a
CC       sphingomyelin + a 1,2-diacyl-sn-glycerol.
CC   -!- ENZYME REGULATION: Inhibited by bacterial PC-phospholipase C
CC       inhibitor D609. {ECO:0000269|PubMed:14685263}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:14685263, ECO:0000269|PubMed:17449912,
CC       ECO:0000269|PubMed:18694848}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14685263, ECO:0000269|PubMed:17449912,
CC       ECO:0000269|PubMed:18694848}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86VZ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86VZ5-2; Sequence=VSP_027223, VSP_027224;
CC   -!- TISSUE SPECIFICITY: Brain, heart, kidney, liver, muscle and
CC       stomach. {ECO:0000269|PubMed:11841947,
CC       ECO:0000269|PubMed:14685263, ECO:0000269|PubMed:15315829}.
CC   -!- MISCELLANEOUS: Overexpression of the human protein in mouse causes
CC       increased non-HDL-sphingomyelin and non-HDL cholesterol levels,
CC       decreased HDL-sphingomyelin and HDL-cholesterol levels and
CC       increases lipoprotein atherogenic potential.
CC   -!- SIMILARITY: Belongs to the sphingomyelin synthase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH42899.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=AAP37279.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=AAQ22363.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=AAQ82051.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=AK026683; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=BAD16809.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=CAD79708.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB154421; BAD16809.1; ALT_SEQ; mRNA.
DR   EMBL; AY280959; AAP37279.1; ALT_SEQ; mRNA.
DR   EMBL; AY312431; AAQ82051.1; ALT_SEQ; mRNA.
DR   EMBL; AK026683; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC069547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117341; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042899; AAH42899.1; ALT_SEQ; mRNA.
DR   EMBL; AY364088; AAR13294.1; -; mRNA.
DR   EMBL; AY332650; AAQ22363.1; ALT_SEQ; mRNA.
DR   EMBL; BN000143; CAD79708.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_671512.1; NM_147156.3.
DR   RefSeq; XP_005269732.1; XM_005269675.1.
DR   RefSeq; XP_011537884.1; XM_011539582.2.
DR   RefSeq; XP_011537885.1; XM_011539583.2.
DR   UniGene; Hs.654698; -.
DR   ProteinModelPortal; Q86VZ5; -.
DR   SMR; Q86VZ5; -.
DR   BioGrid; 129227; 3.
DR   IntAct; Q86VZ5; 1.
DR   MINT; MINT-2879302; -.
DR   STRING; 9606.ENSP00000354829; -.
DR   BindingDB; Q86VZ5; -.
DR   ChEMBL; CHEMBL3611965; -.
DR   GuidetoPHARMACOLOGY; 2520; -.
DR   SwissLipids; SLP:000000171; -.
DR   iPTMnet; Q86VZ5; -.
DR   PhosphoSitePlus; Q86VZ5; -.
DR   BioMuta; SGMS1; -.
DR   DMDM; 44888473; -.
DR   MaxQB; Q86VZ5; -.
DR   PaxDb; Q86VZ5; -.
DR   PeptideAtlas; Q86VZ5; -.
DR   PRIDE; Q86VZ5; -.
DR   GeneID; 259230; -.
DR   KEGG; hsa:259230; -.
DR   CTD; 259230; -.
DR   DisGeNET; 259230; -.
DR   GeneCards; SGMS1; -.
DR   HGNC; HGNC:29799; SGMS1.
DR   HPA; HPA045191; -.
DR   MIM; 611573; gene.
DR   neXtProt; NX_Q86VZ5; -.
DR   PharmGKB; PA162403042; -.
DR   eggNOG; KOG3058; Eukaryota.
DR   eggNOG; ENOG410XNSC; LUCA.
DR   HOGENOM; HOG000233822; -.
DR   HOVERGEN; HBG048216; -.
DR   InParanoid; Q86VZ5; -.
DR   KO; K04714; -.
DR   PhylomeDB; Q86VZ5; -.
DR   BRENDA; 2.7.8.27; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; SGMS1; human.
DR   GeneWiki; SGMS1; -.
DR   GenomeRNAi; 259230; -.
DR   PRO; PR:Q86VZ5; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000198964; -.
DR   CleanEx; HS_SGMS1; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:HGNC.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0000138; C:Golgi trans cisterna; IDA:MGI.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:HGNC.
DR   GO; GO:0005886; C:plasma membrane; TAS:HGNC.
DR   GO; GO:0047493; F:ceramide cholinephosphotransferase activity; IDA:UniProtKB.
DR   GO; GO:0002950; F:ceramide phosphoethanolamine synthase activity; IDA:MGI.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0033188; F:sphingomyelin synthase activity; IMP:HGNC.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0016049; P:cell growth; IDA:HGNC.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:MGI.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006686; P:sphingomyelin biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR025749; Sphingomyelin_synth-like_dom.
DR   Pfam; PF14360; PAP2_C; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Golgi apparatus;
KW   Kinase; Lipid metabolism; Membrane; Phosphoprotein;
KW   Reference proteome; Sphingolipid metabolism; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    419       Phosphatidylcholine:ceramide
FT                                cholinephosphotransferase 1.
FT                                /FTId=PRO_0000221068.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    310    330       Helical. {ECO:0000255}.
FT   TOPO_DOM    331    419       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       13     76       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184, ECO:0000305}.
FT   ACT_SITE    291    291       {ECO:0000269|PubMed:18694848}.
FT   ACT_SITE    334    334       {ECO:0000269|PubMed:18694848}.
FT   ACT_SITE    338    338       {ECO:0000269|PubMed:18694848}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    205       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15315829}.
FT                                /FTId=VSP_027223.
FT   VAR_SEQ     206    214       IQWLLLKYK -> MTRMFLNNP (in isoform 2).
FT                                {ECO:0000303|PubMed:15315829}.
FT                                /FTId=VSP_027224.
FT   MUTAGEN     289    289       S->A: Completely abolishes enzyme
FT                                activity. No change in subcellular
FT                                location. {ECO:0000269|PubMed:18694848}.
FT   MUTAGEN     291    291       H->A: Completely abolishes enzyme
FT                                activity. No change in subcellular
FT                                location. {ECO:0000269|PubMed:18694848}.
FT   MUTAGEN     334    334       H->A: Completely abolishes enzyme
FT                                activity. No change in subcellular
FT                                location. {ECO:0000269|PubMed:18694848}.
FT   MUTAGEN     338    338       D->A: Completely abolishes enzyme
FT                                activity. No change in subcellular
FT                                location. {ECO:0000269|PubMed:18694848}.
FT   CONFLICT    168    168       P -> L (in Ref. 3; AAQ82051).
FT                                {ECO:0000305}.
SQ   SEQUENCE   419 AA;  49208 MW;  52C2A985E3F27E44 CRC64;
     MLSASTMKEV VYWSPKKVAD WLLENAMPEY CEPLEHFTGQ DLINLTQEDF KKPPLCRVSS
     DNGQRLLDMI ETLKMEHHLE AHKNGHANGH LNIGVDIPTP DGSFSIKIKP NGMPNGYRKE
     MIKIPMPELE RSQYPMEWGK TFLAFLYALS CFVLTTVMIS VVHERVPPKE VQPPLPDTFF
     DHFNRVQWAF SICEINGMIL VGLWLIQWLL LKYKSIISRR FFCIVGTLYL YRCITMYVTT
     LPVPGMHFNC SPKLFGDWEA QLRRIMKLIA GGGLSITGSH NMCGDYLYSG HTVMLTLTYL
     FIKEYSPRRL WWYHWICWLL SVVGIFCILL AHDHYTVDVV VAYYITTRLF WWYHTMANQQ
     VLKEASQMNL LARVWWYRPF QYFEKNVQGI VPRSYHWPFP WPVVHLSRQV KYSRLVNDT
//
